| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Lansoprazole | FAERS: 4 | US FAERS | |
| 2 | Canagliflozin | FAERS: 2 | US FAERS | |
| 3 | Lenalidomide | FAERS: 2 | US FAERS | |
| 4 | Celecoxib | FAERS: 1 | US FAERS | |
| 5 | Enalapril | FAERS: 1 | US FAERS | |
| 6 | Ergotamine | FAERS: 1 | US FAERS | |
| 7 | Everolimus | FAERS: 1 | US FAERS | |
| 8 | Hydroxychloroquine | FAERS: 1 | US FAERS | |
| 9 | Hydroxychloroquine | FAERS: 1 | US FAERS | |
| 10 | Ibuprofen | FAERS: 1 | US FAERS | |
| 11 | Lamotrigine | FAERS: 1 | US FAERS | |
| 12 | Methotrexate | FAERS: 1 | US FAERS | |
| 13 | Pravastatin | FAERS: 1 | US FAERS | |
| 14 | Ampicillin | Canada Vigilance: 1 | Canada Vigilance | |
| 15 | Gold Sodium Thiomalate | Canada Vigilance: 1 | Canada Vigilance | |
| 16 | Naproxen | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.